ImmunoPrecise Antibodies to Participate at the AI Driven Drug Discovery Summit USA 2024
ImmunoPrecise Antibodies Ltd. (IPA)
Company Research
Source: Business Wire
VICTORIA, British Columbia--(BUSINESS WIRE)--ImmunoPrecise Antibodies Ltd. (the “Company” or “IPA”) (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, today announced that Dr. Dirk Van Hyfte, Head of Innovation at BioStrand, IPA’s AI subsidiary, will participate on a Fireside Chat during the AI Driven Drug Discovery Summit USA 2024 taking place at the Aloft Boston Seaport District Hotel, Boston, Massachusetts, November 12-14, 2024.AI Driven Drug Discovery SummitDate: Thursday, November 14Time: 11:30 pm ESTFormat: Fireside ChatTo register for the event, please click HereMeet with usFor appointment scheduling, please contact Jennifer K. Zimmons, PhD, MBA, at Quantum Media: jen@quantum-corp.com, +1.917.214.3514.About ImmunoPrecise Antibodies Ltd.ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series proprietary and patented technologies. The Company owns an integrated e
Show less
Read more
Impact Snapshot
Event Time:
IPA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IPA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IPA alerts
High impacting ImmunoPrecise Antibodies Ltd. news events
Weekly update
A roundup of the hottest topics
IPA
News
- $20 Billion Market Breakthrough: IPA Pioneers High-Impact Antibody Development for Next-Generation ADC Cancer TherapiesBusiness Wire
- ImmunoPrecise to Host TECHDAY: Cutting-Edge AI and Biologics Innovation [Yahoo! Finance]Yahoo! Finance
- ImmunoPrecise to Host TECHDAY: Cutting-Edge AI and Biologics InnovationBusiness Wire
- ImmunoPrecise Advances Anti-Aging Research with Mayo Clinic Study, Poised to Tap into $81 Billion Market with AI TechnologyBusiness Wire
- ImmunoPrecise Antibodies Celebrates Nobel Prize in Chemistry, Advances in AI-Powered Protein Design [Yahoo! Finance]Yahoo! Finance
IPA
Earnings
- 9/16/24 - Miss
IPA
Analyst Actions
- 9/17/24 - HC Wainwright
IPA
Sec Filings
- 11/18/24 - Form 6-K
- 11/13/24 - Form 6-K
- 11/4/24 - Form 6-K
- IPA's page on the SEC website